Diagnostic Technologies

BioMérieux subsidiary secures DoD contract for infectious disease testing system

BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.

September 29, 2023

AI model reveals kidney tumor features, potential for treatment response prediction

Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.

September 22, 2023

Consumer genetic testing may misrepresent breast cancer risk: Study

Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.

September 21, 2023

Rome Therapeutics raises $72M in series B financing

Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”

September 20, 2023

Many British health trusts slow to adopt electronic records systems, shows BMJ survey

Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.

September 22, 2023

Danaher cuts cost of rapid TB test after years of pressure from activists

Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.

September 21, 2023

Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study

Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.

September 21, 2023

Researchers develop signature for scoring thyroid cancers

A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.

September 20, 2023

Broken String Biosciences raises $15M in series A financing round

Broken String Biosciences has closed a $15 million series A financing round.

September 19, 2023

NIH’s systematic review finds AI may improve detection of underdiagnosed condition

A systematic review of earlier studies has found that artificial intelligence (AI) and machine learning (ML) can support the diagnosis of polycystic ovarian syndrome (PCOS).

September 19, 2023

Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer

Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.

September 18, 2023

Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection

Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in Science Advances.

September 18, 2023

Page 1 of 299

Next Page